BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1835742)

  • 21. [Anti-H2 and omeprazole in brief therapy of peptic ulcer].
    Piai G; Sabbatini F; Mazzacca G
    Ann Ital Chir; 1990; 61(1):11-4. PubMed ID: 1978622
    [No Abstract]   [Full Text] [Related]  

  • 22. Current status of cimetidine in acid-peptic disorders.
    Romankiewicz JA; Reidenberg MM
    Ration Drug Ther; 1981 May; 15(5):1-5. PubMed ID: 6984516
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acid inhibitors for asthma patients].
    Füessl HS
    MMW Fortschr Med; 2005 Oct; 147(42):4-5. PubMed ID: 16281772
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects.
    Kim HK; Park SH; Cheung DY; Cho YS; Kim JI; Kim SS; Chae HS; Kim JK; Chung IS
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1618-25. PubMed ID: 20880169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 32. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.
    Orlando RC
    Am J Gastroenterol; 1996 Sep; 91(9):1692-6. PubMed ID: 8792683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of omeprazole on serum gastrin levels: influence of age and sex.
    Koop H; Naumann-Koch C; Arnold R
    Z Gastroenterol; 1990 Nov; 28(11):603-5. PubMed ID: 1981116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cimetidine: a review (author's transl)].
    Hoffenberg P
    Rev Med Chil; 1979 Mar; 107(3):245-50. PubMed ID: 38497
    [No Abstract]   [Full Text] [Related]  

  • 37. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; gastric mucosa proton pump inhibitors].
    Okabe S; Akimoto Y
    Nihon Rinsho; 1988 Jan; 46(1):33-8. PubMed ID: 2836641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

  • 39. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cimetidine; new hope for ulcer patients?].
    Festen HP; Lamersen CB; van Tongeren JH
    Ned Tijdschr Geneeskd; 1978 Jun; 122(24):866-70. PubMed ID: 351434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.